In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates

International Journal of Antimicrobial Agents

Volumn 45, Issue 1, 2015, Pages 71-75

  Zhang, Zhijian ^a,b   Li, Tianzhi ^a   Qu, Geping ^a   Pang, Yu ^a,b   Zhao, Yanlin ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Clofazimine; Multidrug resistance; Synergy; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; CLOFAZIMINE; ETHAMBUTOL; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DRUG POTENTIATION; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHINA; CLOFAZIMINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84920479317     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.09.012     Document Type: Article

References (16)

1. J.A. Caminero, G. Sotgiu, A. Zumla, and G.B. Migliori Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis Lancet Infect Dis 10 2010 621 629
2. World Health Organization. Global tuberculosis report 2012. Geneva, Switzerland: WHO; 2012.
3. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update. Geneva, Switzerland: WHO; 2011.
4. A. Van Deun, A.K. Maug, M.A. Salim, P.K. Das, M.R. Sarker, and P. Daru Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis Am J Respir Crit Care Med 182 2010 684 692
5. M.C. Cholo, H.C. Steel, P.B. Fourie, W.A. Germishuizen, and R. Anderson Clofazimine: current status and future prospects J Antimicrob Chemother 67 2012 290 298
6. Y. Zhao, S. Xu, L. Wang, D.P. Chin, S. Wang, and G. Jiang National survey of drug-resistant tuberculosis in China N Engl J Med 366 2012 2161 2170
7. L. Collins, and S.G. Franzblau Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium Antimicrob Agents Chemother 41 1997 1004 1009
8. J. van Ingen, S. Simons, R. de Zwaan, T. van der Laan, M. Kamst-van Agterveld, and M.J. Boeree Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates J Clin Microbiol 48 2010 2749 2753
9. Y. Kohno, H. Ohno, Y. Miyazaki, Y. Higashiyama, K. Yanagihara, and Y. Hirakata In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan Antimicrob Agents Chemother 51 2007 4071 4076
10. Z. Zhang, Y. Pang, Y. Wang, C. Liu, and Y. Zhao Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China Int J Antimicrob Agents 43 2014 231 235
11. P.E. Almeida Da Silva, and J.C. Palomino Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs J Antimicrob Chemother 66 2011 1417 1430
12. E. Rey-Jurado, G. Tudó, J.P. de la Bellacasa, M. Espasa, and J. González-Martín In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates Int J Antimicrob Agents 41 2013 278 280
13. J. van Ingen, S.E. Totten, N.K. Helstrom, L.B. Heifets, M.J. Boeree, and C.L. Daley In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease Antimicrob Agents Chemother 56 2012 6324 6327
14. A.A. Velayati, P. Farnia, T.A. Ibrahim, R.Z. Haroun, H.O. Kuan, and J. Ghanavi Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy Chemotherapy 55 2009 303 307
15. V.C. Barry, J.G. Belton, M.L. Conalty, J.M. Denneny, D.W. Edward, and J.F. O'Sullivan A new series of phenazines (rimino-compounds) with high antituberculosis activity Nature 179 1957 1013 1015
16. M. Wilmes, B.P. Cammue, H.G. Sahl, and K. Thevissen Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation Nat Prod Rep 28 2011 1350 1358